NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT00053989 2020-02-10NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRoswell Park Cancer InstitutePhase 2 Completed41 enrolled 13 charts
NCT00521430 2013-03-26Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseNational Cancer Institute (NCI)Phase NA Completed30 enrolled